Spinally delivered N-, P/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice

Life Sciences

Volumn 73, Issue 22, 2003, Pages 2873-2881

  Fukuizumi, Tadaoki ^a   Ohkubo, Tsuyako ^a   Kitamura, Kenji ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Analgesia; Morphine; Synergistic effect; Voltage dependent Ca2+ channel blocker

Indexed keywords

CALCISEPTINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM ION; DYE; MORPHINE; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; ELECTRIC POTENTIAL; LOW DRUG DOSE; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN THRESHOLD; SPINAL ANESTHESIA; TAIL FLICK TEST; THERMAL STIMULATION;

EID: 0141606647     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00700-8     Document Type: Article

References (31)

1. Antkiewicz-Michaluk L., Michaluk J., Romanska I., Vetulani J. Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology (Berl). 111(4):1993;457-464.
2. Aosaki T., Kasai H. Characterization of two kinds of high-voltage-activated Ca-channel currents in chick sensory neurons. Pflügers Archiv. 414(2):1989;150-156.
3. Bleakman D., Bowman D., Bath C.P., Brust P.F., Johnson E.C., Deal C.R., Miller R.J., Ellis S.B., Harpold M.M., Hans M., Grantham C.J. Characteristics of a human N-type calcium channel expressed in HEK293 cells. Neuropharmacology. 34(7):1995;753-765.
4. Chapman D.B., Way E.L. Modification of endorphin/enkephalin analgesia and stress-induced analgesia by divalent cations, a cation chelator and an ionophore. British Journal of Pharmacology. 75(2):1982;389-396.
5. Coderre T.J., Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. Journal of Neuroscience. 12(9):1992;3671-3675.
6. Contreras E., Tamayo L., Amigo M. Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. European Journal of Pharmacology. 148(3):1988;463-466.
7. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. The Journal of Pharmacology and Experimental Therapeutics. 72(1):1941;74-79.
8. Del Pozo E., Ruiz-Garcia C., Baeyens J.M. Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test. General Pharmacology. 21(5):1990;681-685.
9. de Weille J.R., Schweitz H., Maes P., Tartar A., Lazdunski M. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proceedings of the National Academy of Sciences of the United States of America. 88(6):1991;2437-2440.
10. 2+ channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. Pain. 69(1-2):1997;93-100.
11. Diochot S., Richard S., Baldy-Moulinier M., Nargeot J., Valmier J. Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents. Pflügers Archiv. 431(1):1995;10-19.
12. Dogrul A., Yesilyurt O. Effects of intrathecally administered aminoglycoside antibiotics, calcium-channel blockers, nickel and calcium on acetic acid-induced writhing test in mice. General Pharmacology. 30(4):1998;613-616.
13. Harris R.A., Loh H.H., Way E.L. Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. The Journal of Pharmacology and Experimental Therapeutics. 195(3):1975;488-498.
14. Hatakeyama S., Wakamori M., Ino M., Miyamoto N., Takahashi E., Yoshinaga T., Sawada K., Imoto K., Tanaka I., Yoshizawa T., Nishizawa Y., Mori Y., Niidome T., Shoji S. Differential nociceptive responses in mice lacking the alpha(1B) subunit of N-type Ca(2+) channels. NeuroReport. 12(11):2001;2423-2427.
15. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. European Journal of Pharmacology. 67(2-3):1980;313-316.
16. Katayama S., Kito S., Miyoshi R., Matsubayashi H. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain. Brain Research. 422(1):1987;168-171.
17. 2+ channels in synaptic transmission. British Journal of Pharmacology. 135(5):2002;1336-1342.
18. Kim C., Jun K., Lee T., Kim S.S., McEnery M.W., Chin H., Kim H.L., Park J.M., Kim D.K., Jung S.J., Kim J., Shin H.S. Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel. Molecular and Cellular Neuroscience. 18(2):2001;235-245.
19. Malmberg A.B., Yaksh T.L. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. Journal of Neuroscience. 14(8):1994;4882-4890.
20. Mintz I.M., Bean B.P. Block of calcium channels in rat neurons by synthetic omega-Aga-IVA. Neuropharmacology. 32(11):1993;1161-1169.
21. 2+ channel blockers. European Journal of Pharmacology. 217(2-3):1992;137-141.
22. Ogasawara M., Kurihara T., Hu Q., Tanabe T. Characterization of acute somatosensory pain transmission in P/Q-type Ca(2+) channel mutant mice, leaner. Federation of European Biochemical Societies Letters. 508(2):2001;181-186.
23. Ohkubo T., Shibata M., Takahashi H., Inoki R. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. The Journal of Pharmacology and Experimental Therapeutics. 252(3):1990;1261-1268.
24. Omote K., Sonoda H., Kawamata M., Iwasaki H., Namiki A. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology. 79(4):1993;746-752.
25. Pereira I.T., Prado W.A., Dos Reis M.P. Enhancement of the epidural morphine-induced analgesia by systemic nifedipine. Pain. 53(3):1993;341-345.
26. 2+ channel. The European Molecular Biology Organization Journal. 20(10):2001;2349-2356.
27. Sather W.A., Tanabe T., Zhang J.F., Mori Y., Adams M.E., Tsien R.W. Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits. Neuron. 11(2):1993;291-303.
28. Suzuki Y., Goto K., Shiizaki K., Omiya Y., Ishige A., Komatsu Y., Kamei J. Antinociceptive effect of U-50488H, a k-opioid agonist, in streptozotocin-induced diabetic mice. Journal of Pharmacy and Pharmacology. 53(4):2001;521-526.
29. Vanegas H., Schaible H. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain. 85(1-2):2000;9-18.
30. 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. Journal of Neuroscience. 18(16):1998;6319-6330.
31. 2+ channels in supporting hippocampal synaptic transmission. Science. 264(5155):1994;107-111.